Biotech Acquisition Co

Biotech Acquisition Co, trading under the ticker BIOT, is a blank-check company formed to pursue a business combination within the biotechnology and life sciences sector. The SPAC completed its initial public offering in 2021 and filed a Form 10-Q with the SEC on May 24, 2021, reflecting its status as an active search-stage vehicle targeting innovation-driven companies in the healthcare and biotech space. At the time of filing, the company had not yet identified or announced a definitive merger target. Investors and researchers tracking BIOT's deal activity, financials, and filing history can access full data, including SEC document links and timeline analysis, by signing up at SpacDesk.